Scivita Medical Technology Co., Ltd.
PrivateLast Round
Series B
Aug 5, 2021
Est. Valuation
$1.06B
Total Funding Raised
$123.57M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Scivita Medical Technology Co., Ltd. operates in Healthcare & Life Sciences and is based in Suzhou. Its latest recorded funding round was a Series B round in August 2021.
Scivita Medical Technology Co., Ltd. is a medical device company that specializes in the research, development, and commercialization of minimally invasive endoscopic imaging solutions and related medical products.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Scivita Medical Technology Co., Ltd. Comparables
Compare Scivita Medical Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Innovex Medical Co., Ltd. | 89% | |
| Hunan Vathin Medical Instrument Co., Ltd. | 87% | |
| 广东欧谱曼迪科技股份有限公司 | 84% |
For institutional investors. Book with your work email.
Scivita Medical Technology Co., Ltd. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Scivita Medical Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Matrix | Series B, Series A |
| Hillhouse Investment | Series B, Series A |
| Chengwei Capital | Series A |
| MPC | Series B, Series A |
| Prime Capital AG | Series B |
| Lilly Asia Ventures | Series B, Series A |
| Hudson Bay Capital Management | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors grew 64% MoM, from 798 to 1.3K.
- Aug 20, 2026
Monthly visitors increased 2180% from 35 to 798.
For institutional investors. Book with your work email.
Scivita Medical Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Scivita Medical Technology Co., Ltd.'s valuation, stock price, and market status.
Is Scivita Medical Technology Co., Ltd. a public or private company?
Scivita Medical Technology Co., Ltd. is a private company.
What is the current stock price of Scivita Medical Technology Co., Ltd.?
Scivita Medical Technology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Scivita Medical Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Scivita Medical Technology Co., Ltd. worth (valuation)?
Scivita Medical Technology Co., Ltd.'s valuation is estimated at $1.1B based on funding round data.
Can I buy Scivita Medical Technology Co., Ltd. stock?
Scivita Medical Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Scivita Medical Technology Co., Ltd.'s last funding round?
Scivita Medical Technology Co., Ltd.'s most recent funding round was Series B on August 5, 2021.
Who are the main investors in Scivita Medical Technology Co., Ltd.?
Key investors in Scivita Medical Technology Co., Ltd. include Hillhouse Investment, Lilly Asia Ventures, Lilly Asia Ventures.
Will Scivita Medical Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Scivita Medical Technology Co., Ltd..
How can I track Scivita Medical Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Scivita Medical Technology Co., Ltd.'s shares on secondary markets.